[go: up one dir, main page]

AR122715A1 - ANTIBODIES AND METHODS TO TREAT CLAUDIN-ASSOCIATED DISEASES - Google Patents

ANTIBODIES AND METHODS TO TREAT CLAUDIN-ASSOCIATED DISEASES

Info

Publication number
AR122715A1
AR122715A1 ARP210101726A ARP210101726A AR122715A1 AR 122715 A1 AR122715 A1 AR 122715A1 AR P210101726 A ARP210101726 A AR P210101726A AR P210101726 A ARP210101726 A AR P210101726A AR 122715 A1 AR122715 A1 AR 122715A1
Authority
AR
Argentina
Prior art keywords
antibodies
claudin
treat
methods
associated diseases
Prior art date
Application number
ARP210101726A
Other languages
Spanish (es)
Inventor
Bing Hou
Peng Chen
Hui Yuwen
Bo Shan
Jay Mei
Original Assignee
Antengene Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antengene Biologics Ltd filed Critical Antengene Biologics Ltd
Publication of AR122715A1 publication Critical patent/AR122715A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación proporciona anticuerpos anti CLDN18 o fragmentos de unión a antígeno de estos, polinucleótidos aislados que los codifican, composiciones farmacéuticas que los comprenden y los usos de estos.The present disclosure provides anti-CLDN18 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding them, pharmaceutical compositions comprising them, and uses thereof.

ARP210101726A 2020-06-23 2021-06-23 ANTIBODIES AND METHODS TO TREAT CLAUDIN-ASSOCIATED DISEASES AR122715A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2020097635 2020-06-23

Publications (1)

Publication Number Publication Date
AR122715A1 true AR122715A1 (en) 2022-09-28

Family

ID=83444638

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101726A AR122715A1 (en) 2020-06-23 2021-06-23 ANTIBODIES AND METHODS TO TREAT CLAUDIN-ASSOCIATED DISEASES

Country Status (1)

Country Link
AR (1) AR122715A1 (en)

Similar Documents

Publication Publication Date Title
CO2023000557A2 (en) Antibodies and methods for treating claudin-associated diseases
MX2025000370A (en) Anti-ctla4 antibodies and methods of making and using the same
CL2020003028A1 (en) Anti-cd33 antibodies, anti-cd33 / anti-cd3 bispecific antibodies and their uses.
MX2020009366A (en) ANTI-CD73 ANTIBODIES AND THEIR USES.
AR120883A1 (en) ANTI-FGFR2B ANTIBODIES
AR120886A1 (en) ANTI-FGFR2B ANTIBODIES
CL2022000368A1 (en) Therapeutic uses of anti-tcr delta 1 variable antibodies
AR111288A1 (en) ANTI-PHF-TAU ANTIBODIES AND ITS USES
PE20181367A1 (en) AGONIST ANTIBODIES THAT SPECIFICALLY BIND HUMAN CD40 AND METHODS OF USE
CL2025000403A1 (en) Anti-Lilrb1 antibody and its uses
MX2020011914A (en) Anti-dll3 antibodies and uses thereof.
MX2022014896A (en) ANTI-CLDN18.2 ANTIBODIES AND USES FOR DIAGNOSIS THEREOF.
CO2024013551A2 (en) New anti-cd3 antibodies and their uses
ECSP23076906A (en) COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)
CO2021014768A2 (en) Anti-sema3a antibodies and their uses to treat eye diseases
AR120884A1 (en) ANTI-FGFR2B ANTIBODIES
MX2020009522A (en) ANTI-FOLATE ANTIBODIES OF RECEPTOR 1 AND THEIR USES.
CL2021001615A1 (en) Anti-il-36 antibodies and procedures for their use
CL2025000292A1 (en) TMEM219 antibodies and their therapeutic uses
MX2020009130A (en) Therapeutic anti-spla2-gib antibodies and the uses thereof.
MX2021004356A (en) Formulations of anti-rsv antibodies and methods of use thereof.
PE20230255A1 (en) ANTI-OX40 ANTIBODY AND USES THEREOF
MX2021015501A (en) ANTIBODIES AND METHODS OF USE.
CL2022001120A1 (en) Anti-t-cell immunoreceptor antibodies with immunoglobulin domains and immunoreceptor tyrosine-based inhibitory motif (tigit) and their uses
DOP2024000117A (en) ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES IN TREATING OPHTHALMIC OR OCULAR DISEASES